Global expansion Certis Biologicals has a world-wide footprint with presence in the U.S. and over 50 countries, recent EU acquisitions and launches (NemaClean in Netherlands) indicate ongoing international growth and potential for cross-border bio-solutions sales and regulatory enablement.

Product expansion New and acquired biocontrol products and fungicides (Howler, Theia, Convergence, NemaClean) signal a broadening portfolio across biofungicides, bioinsecticides, bionematicides, and plant health products—opportunity to upsell integrated biological crop protection programs.

Facility investment Recent expansions of research and manufacturing facilities in Wasco and Columbia, plus vertical integration, suggest capacity to scale production for new product lines and regional demand, enabling reliable supply for larger retail and grower accounts.

Leadership momentum Executive changes and strengthened leadership (new president Eda Reinot) point to a strategic push and credibility in North American markets, aiding enterprise-level deals, partnerships, and channel expansion with retailers and advisors.

Sustainability focus A long-standing emphasis on resistance management, soil health, and sustainable crop protection aligns with market trends favoring biologicals, offering opportunities to position Certis as a preferred partner for growers seeking sustainable licenses, certifications, and ecosystem-beneficial programs.